GPR37 was found to be upregulated in oligodendrocytes of the substantia nigra in parkinsonian mice, and prosaposin (PSAP) secretion was increased in these models.

Neuropathology Score: 0.500 Price: $0.50 Parkinson's disease animal_model Status: extracted

What This Experiment Tests

Neuropathology experiment designed to assess clinical efficacy targeting GPR37 in animal_model. Primary outcome: GPR37 was found to be upregulated in oligodendrocytes of the substantia nigra in parkinsonian mice,

Description

Examination of oligodendrocyte gene expression changes in substantia nigra of parkinsonian mouse models

TARGET GENE
MODEL SYSTEM
animal_model
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
prosaposin-GPR37-IL-6 axis
SOURCE
pmid_39913287
PRIMARY OUTCOME
GPR37 was found to be upregulated in oligodendrocytes of the substantia nigra in parkinsonian mice, and prosaposin (PSAP) secretion was increased in these models.

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.500 composite

Related Hypotheses (2)

Astrocyte C3aR Signaling as Bifurcation Point for A1/A2 Fate0.749
Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution0.680

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.